Breaking News Instant updates and real-time market news.

DKS

Dick's Sporting

$27.57

0.7 (2.61%)

, TEVA

Teva

$17.78

-0.19 (-1.06%)

10:37
08/16/17
08/16
10:37
08/16/17
10:37

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Dick's Sporting (DKS) was downgraded to Neutral from Buy at Monness Crespi, Goldman Sachs, MKM Partners, Buckingham, Citi, and to Neutral from Positive at Susquehanna, while being downgraded to Hold from Buy at Deutsche Bank and to Sector Perform from Outperform at RBC Capital. 2. Teva (TEVA) downgraded to Neutral from Buy at Citi with analyst Liav Abraham saying Teva is "cheap, but not cheap enough." 3. Advance Auto Parts (AAP) downgraded to Neutral from Overweight at Atlantic Equities with analyst Sam Hudson citing limited near-term visibility. 4. SL Green Realty (SLG) and Kilroy Realty (KRC) were downgraded to Neutral from Buy at BofA/Merrill, while Gramercy Property Trust (GPT) was downgraded to Underperform from Neutral. 5. CB&I (CBI) downgraded to Hold from Buy at Jefferies with analyst Martin Englert saying he is concerned that cost overruns at the company's two LNG projects could reemerge, adding risk to 2017-2019 earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

DKS

Dick's Sporting

$27.57

0.7 (2.61%)

TEVA

Teva

$17.78

-0.19 (-1.06%)

AAP

Advance Auto Parts

$88.57

1.49 (1.71%)

SLG

SL Green Realty

$99.52

0.05 (0.05%)

KRC

Kilroy Realty

$69.90

-0.07 (-0.10%)

GPT

Gramercy Property Trust

$29.15

-0.32 (-1.09%)

CBI

CB&I

$10.59

-0.605 (-5.41%)

  • 22

    Aug

  • 23

    Aug

  • 30

    Aug

DKS Dick's Sporting
$27.57

0.7 (2.61%)

08/16/17
GSCO
08/16/17
DOWNGRADE
Target $30
GSCO
Neutral
Dick's Sporting downgraded to Neutral from Buy at Goldman Sachs
Goldman analyst Stephen Tanal downgraded Dick's Sporting Goods to Neutral and slashed its price target to $30 from $49 following the Q2 report and reduced outlook resulting in a reduction in forecasts.
08/16/17
MONN
08/16/17
DOWNGRADE
MONN
Neutral
Dick's Sporting downgraded to Neutral from Buy at Monness Crespi
Monness Crespi analyst Jim Chartier downgraded Dick's Sporting Goods to Neutral following the company's Q2 results.
08/16/17
SUSQ
08/16/17
DOWNGRADE
Target $30
SUSQ
Neutral
Dick's Sporting downgraded to Neutral from Positive at Susquehanna
Susquehanna analyst Sam Poser downgraded Dick's Sporting Goods to Neutral and cut his price target for the shares to $30 from $57 following the company's Q2 results.
08/16/17
MKMP
08/16/17
DOWNGRADE
MKMP
Neutral
Dick's Sporting downgraded to Neutral from Buy at MKM Partners
MKM Partners analyst Patrick McKeever,downgraded Dick's, saying that the company's results appear to have deteriorated significantly during the course of Q2. The analyst says that the company was hurt by increased promotion and wider distribution of key brands by competitors. Target $30.
TEVA Teva
$17.78

-0.19 (-1.06%)

08/16/17
SBSH
08/16/17
DOWNGRADE
Target $19
SBSH
Neutral
Teva downgraded to Neutral from Buy at Citi
Citi analyst Liav Abraham downgraded Teva Pharmaceutical (TEVA) to Neutral and cut her price target for the shares to $19 from $32. The analyst this morning also upgraded Mylan (MYL) to Buy. Teva is "cheap, but not cheap enough," Abraham tells investors in a research note. She needs to see the appointment of a "respected" CEO and formulation of a credible long-term strategy as well as improvement in the credit situation before getting more constructive on Teva shares.
08/07/17
08/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Teva (TEVA) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst David Risinger saying he underappreciated generic pricing pressure risks on Teva's dividend and expects declining earnings power, combined with high leverage equal to result in a longer recovery. 2. Cummins (CMI) downgraded to Buy from Conviction Buy at Goldman Sachs. 3. RE/MAX Holdings (RMAX) downgraded to Equal Weight from Overweight at Stephens. 4. Intrepid Potash (IPI) downgraded to Sell from Neutral at UBS with analyst John Roberts saying that while bankruptcy risk has been "significantly reduced" since the share count was increased 60% with the March secondary, he remains concerned about the lack of long term growth in non-core income and "still depressed" core potash related income. Roberts cites valuation for his downgrade and raised his price target for Intrepid Potash shares to $2.50 from $2.00. 5. Eaton (ETN) downgraded to In Line from Outperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/07/17
MSCO
08/07/17
DOWNGRADE
Target $16
MSCO
Teva downgraded to Underweight, bear case target $9 at Morgan Stanley
As previously reported, Morgan Stanley downgraded Teva to Underweight from Equal Weight and cut its price target to $16 from $36. Analyst David Risinger said he underappreciated generic pricing pressure risks on Teva's dividend and expects declining earnings power, combined with high leverage equal to result in a longer recovery. He expects core business generic headwinds and Copaxone generic competition to pressure Teva's long-term earnings power and cut his 2017 earnings estimate to $1.24 from $1.55, 2018 earnings estimate to $4.14 from $4.56, and 2019 earnings estimate to $3.79 from $4.50. Risinger's bear case price target on Teva is $9, which assumes much more severe Copaxone erosion and generic business downside.
08/16/17
SBSH
08/16/17
UPGRADE
Target $42
SBSH
Buy
Mylan upgraded to Buy from Neutral at Citi
Citi analyst Liav Abraham upgraded Mylan (MYL) to Buy and raised her price target for the shares to $42 from $36. The company is best positioned to execute in a challenging operating environment for generics, Abraham tells investors in a research note. Mylan has a "differentiated and durable" generics product portfolio, "broad pipeline" of complex generics/ biosimilars and a more favorable balance sheet profile relative to peers, the analyst contends. She has Neutral ratings on Teva (TEVA) and Endo (ENDP).
AAP Advance Auto Parts
$88.57

1.49 (1.71%)

08/16/17
ATLE
08/16/17
DOWNGRADE
Target $93
ATLE
Neutral
Advance Auto Parts downgraded to Neutral from Overweight at Atlantic Equities
Atlantic Equities analyst Sam Hudson downgraded Advance Auto Parts to Neutral from Overweight with a $93 price target citing limited near-term visibility. Hudson said the challenging industry backdrop has pushed out a turnaround until FY18 at the earliest and said negative comps will persist in the second half and near-term margins are difficult to gauge.
08/16/17
DBAB
08/16/17
NO CHANGE
Target $101
DBAB
Buy
Deutsche Bank sticking with Buy rating on Advance Auto Parts
Deutsche Bank analyst Mike Baker lowered his price target to $101 from $139 following the Q2 results but is sticking with his Buy rating on Advance Auto Parts. First and most importantly, the company seems to be stabilizing its market share, the first step in any turnaround, Baker tells investors in a post-earnings research note. He also believes downward earnings revisions should be behind the company and that the current share price assumes little margin recovery.
08/16/17
JPMS
08/16/17
NO CHANGE
Target $106
JPMS
Overweight
Advance Auto Parts price target lowered to $106 from $180 at JPMorgan
JPMorgan analyst Christopher Horvers lowered his price target for Advance Auto Parts to $106 following the company's Q2 results. The analyst expects the inventory cost pressures to continue until inventory per store stabilizes, which he doesn't see until 2019. Horvers believes he and management underappreciated how much investment in the turnaround. He keeps an Overweight rating on Advance Auto.
08/16/17
GABE
08/16/17
NO CHANGE
GABE
Buy
Advance Auto Parts weakness a buying opportunity, says Gabelli
SLG SL Green Realty
$99.52

0.05 (0.05%)

07/13/17
UBSW
07/13/17
UPGRADE
Target $117
UBSW
Buy
SL Green Realty upgraded to Buy at UBS
As reported previously, UBS analyst Nick Yulico upgraded SL Green Realty to Buy from Neutral. The analyst believes NYC Office fundamentals are better than the sentiment on the stock and that 2018 will see occupancy improvement and rent growth from rolling below-market leases. Yulico maintained his $117 price target on SL Green Realty shares.
06/22/17
GSCO
06/22/17
INITIATION
Target $121
GSCO
Buy
SL Green Realty resumed with a Buy at Goldman Sachs
Goldman analyst Andrew Rosivach resumed SL Green Realty with a Buy and a $121 price target given earnings growth and relative valuation.
07/13/17
UBSW
07/13/17
UPGRADE
UBSW
Buy
SL Green Realty upgraded to Buy from Neutral at UBS
08/16/17
BOFA
08/16/17
DOWNGRADE
Target $110
BOFA
Neutral
SL Green Realty downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst James Feldman downgraded SL Green Realty to Neutral and lowered its price target to $110 from $113. The analyst is trimming exposure to New York City given incremental concerns over rent growth and asset prices.
KRC Kilroy Realty
$69.90

-0.07 (-0.10%)

08/14/17
EVER
08/14/17
UPGRADE
Target $78
EVER
Outperform
Kilroy Realty upgraded to Outperform from In Line at Evercore ISI
Evercore ISI analyst Steve Sakwa upgraded Kilroy Realty to Outperform and maintained a $78 price target saying shares are too cheap relative to existing fundamentals and future growth, and expects issues with the Exchange at Mission Bay development project to be resolved within 6-9 months.
08/16/17
BOFA
08/16/17
DOWNGRADE
Target $77
BOFA
Neutral
Kilroy Realty downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst James Feldman downgraded Kilroy Realty to Neutral and lowered its price target to $77 from $80. The analyst believes the impact from known 2018 move outs is reflected in consensus estimates and expects it to weigh on 2018 and 2019 same-store growth. Further, Feldman expects San Diego could be a drag compared to peers.
03/28/17
EVER
03/28/17
UPGRADE
Target $76
EVER
In Line
Kilroy Realty upgraded to In Line from Underperform at Evercore ISI
Evercore ISI analyst Steve Sakwa upgraded Kilroy Realty to In Line and maintained its $76 price target following the recent decline and underperformance of shares relative to the broader REIT sector.
03/03/17
EVER
03/03/17
DOWNGRADE
EVER
Underperform
Kilroy Realty downgraded to Underperform from Hold at Evercore ISI
GPT Gramercy Property Trust
$29.15

-0.32 (-1.09%)

11/02/16
11/02/16
NO CHANGE

Gramercy Property Trust appoints Nicholas Pell as Chief Investment Officer
Gramercy Property Trust appointed Nicholas L. Pell as Chief Investment Officer. Previously, Pell was a Managing Director with Gramercy. His appointment is effective immediately.
08/16/17
BOFA
08/16/17
DOWNGRADE
BOFA
Underperform
Gramercy Property Trust downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill analyst James Feldman downgraded Gramercy Property Trust to Underperform citing relative valuation and headwinds in its industrial portfolio.
01/09/17
JMPS
01/09/17
DOWNGRADE
JMPS
Market Perform
Gramercy Property Trust downgraded to Market Perform at JMP Securities
12/05/16
BOFA
12/05/16
DOWNGRADE
BOFA
Neutral
Gramercy Property Trust downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst James Feldman downgraded Gramercy Property Trust to Neutral due to the rise in the cost of capital and limited upside from accelerating GDP growth given long lease terms of triple nets.
CBI CB&I
$10.59

-0.605 (-5.41%)

08/16/17
AGIS
08/16/17
NO CHANGE
Target $77
AGIS
Buy
W.R. Grace could rally $10 on CB&I unit acquisition, says Aegis
Aegis analyst Chris Kapsch believes Grace (GRA) is likely to become bigger via acquisitions and that CB&I's (CBI) process technology licensing division is a potential target. CB&I is a highly motivated seller, looking to complete the divestiture by year end, Kapsch tells investors in a research note. He believes Grace may be willing to pay as much as $1.5B for the asset and his "rough math" suggests such a deal could be 55c-60c accretive in FY18. This sort of deal accretion could be worth as much as $10 per share for Grace's equity, Kapsch argues. He has a Buy rating on Grace with a $77 price target.
08/11/17
FBCO
08/11/17
NO CHANGE
Target $13
FBCO
Neutral
CB&I price target lowered to $13 from $21 at Credit Suisse
Credit Suisse analyst Jamie Cook said that while CB&I's charges associated with Cameron and Freeport LNG and two gas fired power projects were expected, the $548M magnitude was bigger than expected. Also, unfortunately, since the two LNG projects are not expected to be complete until FY19, the market will "rightfully" remain concerned about potential additional charges, Cook tells investors. Cook lowered his FY17-19 estimates for CB&I and cut his price target on the stock to $13 from $21 while keeping a Neutral rating on the name.
08/10/17
DBAB
08/10/17
NO CHANGE
Target $21
DBAB
Buy
Deutsche Bank lays out path for CB&I shares getting back near $20
Deutsche Bank analyst Chad Dillard says that while CB&I's Q2 results "disappointed significantly," he sees a "clear path" to the shares trading towards the $20 range again should management execute and avoid further cos overruns. Selling the Technology business for 120% of the company's market value, deleveraging and reducing costs by $100M annually would unlock value, Dillard tells investors in a research note titled "2Q Results, A Tough (and Large) Pill to Swallow." The analyst lowered his price target for CB&I shares to $21 from $25 and maintains a Buy rating on the name. The stock in premarket trading is down 22%, or $3.58, to $12.75.
08/16/17
JEFF
08/16/17
DOWNGRADE
Target $12
JEFF
Hold
CB&I downgraded to Hold from Buy at Jefferies
Jefferies analyst Martin Englert downgraded CB&I to Hold and cut his price target for the shares to $12 from $35. The analyst is concerned that cost overruns at the company's two LNG projects could reemerge, adding risk to 2017-2019 earnings.

TODAY'S FREE FLY STORIES

NBLX

Noble Midstream

$55.58

-0.02 (-0.04%)

16:35
01/18/18
01/18
16:35
01/18/18
16:35
Hot Stocks
Salient reports 6.23% passive stake in Noble Midstream »

This stake does not allow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 20

    Feb

HHS

Harte-Hanks

16:35
01/18/18
01/18
16:35
01/18/18
16:35
Hot Stocks
Harte-Hanks COO/CTO Shirish Lal leaving the company »

Harte Hanks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWGH

GWG Holdings

$8.10

-0.2 (-2.41%)

16:35
01/18/18
01/18
16:35
01/18/18
16:35
Hot Stocks
Breaking Hot Stocks news story on GWG Holdings »

GWG Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPB

Spectrum Brands

$121.30

-3.86 (-3.08%)

16:32
01/18/18
01/18
16:32
01/18/18
16:32
Hot Stocks
Spectrum Brands postpones 2018 annual shareholder meeting »

Spectrum Brands Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 30

    Jan

  • 08

    Feb

NTIP

Network-1 Technologies

$2.50

0.05 (2.04%)

, JNPR

Juniper

$27.66

-1.01 (-3.52%)

16:32
01/18/18
01/18
16:32
01/18/18
16:32
Hot Stocks
Network-1 Technologies announces revised patent settlement with Juniper »

Network-1 Technologies…

NTIP

Network-1 Technologies

$2.50

0.05 (2.04%)

JNPR

Juniper

$27.66

-1.01 (-3.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

ENFC

Entegra Financial

$28.90

-0.7 (-2.36%)

16:31
01/18/18
01/18
16:31
01/18/18
16:31
Earnings
Entegra Financial reports Q4 core EPS 54c, consensus 38c »

Reports Q4 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

WYNN

Wynn Resorts

$175.48

1.89 (1.09%)

16:30
01/18/18
01/18
16:30
01/18/18
16:30
Initiation
Wynn Resorts initiated  »

Wynn Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
01/18/18
01/18
16:30
01/18/18
16:30
Options
Preliminary option volume of 20.9M today »

Preliminary option volume…

NTES

NetEase

$322.19

-2.21 (-0.68%)

16:29
01/18/18
01/18
16:29
01/18/18
16:29
Recommendations
NetEase analyst commentary  »

NetEase price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

MS

Morgan Stanley

$55.84

0.49 (0.89%)

, AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

16:25
01/18/18
01/18
16:25
01/18/18
16:25
General news
On The Fly: Top stock stories for Thursday »

Stocks opened little…

MS

Morgan Stanley

$55.84

0.49 (0.89%)

AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

LGF.A

Lionsgate

$34.50

2.22 (6.88%)

LGF.B

Lionsgate

$32.84

2.46 (8.10%)

CBS

CBS

$60.00

1.1 (1.87%)

VIA

Viacom

$39.70

1.85 (4.89%)

VIAB

Viacom

$33.95

1.99 (6.23%)

BA

Boeing

$340.16

-10.85 (-3.09%)

ERJ

Embraer

$24.50

-0.19 (-0.77%)

GNC

GNC Holdings

$5.26

1.79 (51.59%)

PTC

PTC

$69.95

3.25 (4.87%)

AA

Alcoa

$53.00

-3.99 (-7.00%)

ENDP

Endo

$7.35

-0.34 (-4.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 19

    Jan

  • 31

    Jan

  • 01

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 21

    Feb

  • 18

    Mar

SRG

Seritage Growth Properties

$40.37

-0.4 (-0.98%)

16:25
01/18/18
01/18
16:25
01/18/18
16:25
Hot Stocks
Seritage Growth Properties sees FY17 leasing activity 2.6M sqf, up 26% on year »

Seritage Growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNST

Monster Beverage

$66.47

-0.6 (-0.89%)

16:25
01/18/18
01/18
16:25
01/18/18
16:25
Conference/Events
Monster Beverage to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

MGM

MGM Resorts

$36.07

-0.47 (-1.29%)

, WYNN

Wynn Resorts

$175.48

1.89 (1.09%)

16:23
01/18/18
01/18
16:23
01/18/18
16:23
Initiation
MGM Resorts, Wynn Resorts, Eldorado Resorts, Penn National initiated  »

MGM Resorts initiated…

MGM

MGM Resorts

$36.07

-0.47 (-1.29%)

WYNN

Wynn Resorts

$175.48

1.89 (1.09%)

ERI

Eldorado Resorts

$31.60

-0.4 (-1.25%)

PENN

Penn National

$32.26

-0.49 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BANF

BancFirst

$55.20

0.95 (1.75%)

16:22
01/18/18
01/18
16:22
01/18/18
16:22
Hot Stocks
BancFirst to raise company minimum wage »

Executive Chairman David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$23.82

-0.3 (-1.24%)

16:22
01/18/18
01/18
16:22
01/18/18
16:22
Hot Stocks
Meritor realigns segments and leadership positions »

Meritor is realigning its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 13

    Feb

  • 14

    Feb

BANF

BancFirst

$55.20

0.95 (1.75%)

16:21
01/18/18
01/18
16:21
01/18/18
16:21
Earnings
BancFirst reports Q4 EPS 59c, consensus 69c »

Due to the signing of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHN

athenahealth

$125.53

-0.65 (-0.52%)

16:20
01/18/18
01/18
16:20
01/18/18
16:20
Initiation
athenahealth initiated  »

athenahealth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

VIX

Volatility Index S&P 500 Options

16:20
01/18/18
01/18
16:20
01/18/18
16:20
Options
Closing CBOE SPX and VIX Index summary for January 18th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXP

American Express

$99.86

-0.9 (-0.89%)

16:19
01/18/18
01/18
16:19
01/18/18
16:19
Hot Stocks
Breaking Hot Stocks news story on American Express »

American Express down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

MRCY

Mercury Systems

$51.26

-0.45 (-0.87%)

16:19
01/18/18
01/18
16:19
01/18/18
16:19
Hot Stocks
Mercury Systems receives $12.5M electronic surveillance subsystem order »

Mercury Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

HCLP

Hi-Crush Partners

$12.00

-0.05 (-0.41%)

16:18
01/18/18
01/18
16:18
01/18/18
16:18
Hot Stocks
Hi-Crush Partners increases distribution to 20c per unit for Q4 »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFBC

First Financial Bancorp

$27.75

-0.4 (-1.42%)

16:17
01/18/18
01/18
16:17
01/18/18
16:17
Earnings
First Financial Bancorp reports Q4 adjusted EPS 45c, consensus 40c »

Claude Davis, CEO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

$NSD

NASDAQ Market Internals

16:17
01/18/18
01/18
16:17
01/18/18
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRI

Monarch Casino

$45.40

-0.5 (-1.09%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Initiation
Monarch Casino initiated  »

Monarch Casino initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVS

Las Vegas Sands

$73.73

0.22 (0.30%)

16:16
01/18/18
01/18
16:16
01/18/18
16:16
Initiation
Las Vegas Sands initiated  »

Las Vegas Sands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.